Cancer proteogenomics: current impact and future prospects

DR Mani, K Krug, B Zhang, S Satpathy… - Nature Reviews …, 2022 - nature.com
Genomic analyses in cancer have been enormously impactful, leading to the identification of
driver mutations and development of targeted therapies. But the functions of the vast majority …

Integrated proteogenomic characterization across major histological types of pediatric brain cancer

F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury… - Cell, 2020 - cell.com
We report a comprehensive proteogenomics analysis, including whole-genome sequencing,
RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 …

[HTML][HTML] Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin

WW Liang, RJH Lu, RG Jayasinghe, SM Foltz… - Cancer cell, 2023 - cell.com
DNA methylation plays a critical role in establishing and maintaining cellular identity.
However, it is frequently dysregulated during tumor development and is closely intertwined …

Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy

S Migliozzi, YT Oh, M Hasanain, L Garofano… - Nature cancer, 2023 - nature.com
Despite producing a panoply of potential cancer-specific targets, the proteogenomic
characterization of human tumors has yet to demonstrate value for precision cancer …

[HTML][HTML] Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer

S Chowdhury, JJ Kennedy, RG Ivey, OD Murillo… - Cell, 2023 - cell.com
To improve the understanding of chemo-refractory high-grade serous ovarian cancers
(HGSOCs), we characterized the proteogenomic landscape of 242 (refractory and sensitive) …

Proteogenomic characterization of MiT family translocation renal cell carcinoma

Y Qu, X Wu, A Anwaier, J Feng, W Xu, X Pei… - Nature …, 2022 - nature.com
Microphthalmia transcription factor (MiT) family translocation renal cell carcinoma (tRCC) is
a rare type of kidney cancer, which is not well characterized. Here we show the …

Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor

H Zhang, L Bai, XQ Wu, X Tian, J Feng, X Wu… - Nature …, 2023 - nature.com
The tyrosine kinase inhibitor (TKI) Sunitinib is one the therapies approved for advanced
renal cell carcinoma. Here, we undertake proteogenomic profiling of 115 tumors from …

A data analysis framework for combining multiple batches increases the power of isobaric proteomics experiments

JJ O'Brien, A Raj, A Gaun, A Waite, W Li… - Nature …, 2024 - nature.com
We present a framework for the analysis of multiplexed mass spectrometry proteomics data
that reduces estimation error when combining multiple isobaric batches. Variations in the …

Computational systems approach towards phosphoproteomics and their downstream regulation

D **ao, C Chen, P Yang - Proteomics, 2023 - Wiley Online Library
Protein phosphorylation plays an essential role in modulating cell signalling and its
downstream transcriptional and translational regulations. Until recently, protein …

A proteogenomic analysis of cervical cancer reveals therapeutic and biological insights

J Yu, X Gui, Y Zou, Q Liu, Z Yang, J An, X Guo… - Nature …, 2024 - nature.com
Although the incidence of cervical cancer (CC) has been reduced in high-income countries
due to human papillomavirus (HPV) vaccination and screening strategies, it remains a …